That would move the cannabis industry another step closer to getting half the country on board with medical marijuana. Once 25 states allow residents to possess and use cannabis for medical reasons, the federal government will face immense pressure to reconsider its stance on the drug – which could lead to a watershed moment for marijuana businesses.

But also keep your fingers crossed, as the drive to legalize MMJ in New Hampshire faces some daunting odds.

A bill calling for the the legalization of medical cannabis in the state recently cleared two major hurdles, winning approval from lawmakers in both the House and the Senate. Normally, this would be enough to put it on the fast track for approval. But the New Hampshire’s governor has said he will veto it (as he did in 2009), citing concerns with the way it’s written.

All is not lost, however. There’s enough support in the House to nix the veto. Now, the Senate needs to muster up enough support to do the same. The bill’s supporters need to convince two additional Republican senators to switch positions and vote in favor of the measure. If they’re successful, they can override the veto.

How difficult is the task at hand?

Pretty difficult, but not impossible. Most lawmakers opposed to the bill seem pretty entrenched. But MMJ supporters in the Senate have been able to get some of their peers to switch positions – including two this week alone – and several influential lawmakers are now on board.

(See full article here)

Four states and the District of Columbia are moving forward with dispensary programs this year after long delays, clearing the way for a new wave of medical marijuana centers to open. Vermont is the latest to head in this direction, officially starting its dispensary application process this week. The state will allow four dispensaries to sell medical marijuana to registered patients.

Combined, the states and DC will allow nearly 150 dispensaries and dozens of cultivation operations to set up shop – creating a host of new opportunities and helping to strengthen an industry reeling from a government crackdown. Hundreds of related businesses will also form to support these dispensaries and grow facilities, from hydroponics stores and training facilities to law firms and consultancies.

It couldn’t have come at a better time. The Obama administration’s move to shut down dispensaries and put pressure on the industry had created a chilling effect across the country, convincing officials in emerging cannabis states such as Arizona and Rhode Island to put their fledgling MMJ programs on ice or backtrack entirely.

But there’s been a real turn-around as of late, and the tide has decidedly changed as these states rejuvenate their MMJ plans.

Aside from Vermont, other states moving forward this year with dispensary programs include Arizona, New Jersey, Rhode Island and Washington DC. While most of these areas will allow just a handful of dispensaries, Arizona will license up to 126 – meaning it could quickly join the list of powerhouse MMJ states such as Colorado, California and Washington State.

These new businesses will help offset recent industry contraction in California, Colorado and Michigan. They’ll also give MMJ a wider footprint geographically, which could help convince other states to go green as well.

Here’s a breakdown showing the number of dispensaries allowed in each of the four new states plus DC:

Arizona: 126

New Jersey: 6

Rhode Island: 3

Vermont: 4

Washington DC: 5

Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.

• Cancer and colon cancer prevention,

• Inflammatory bowel disease, irritable bowel syndrome, colitis, Crohn’s disease

• Vomiting from chemotherapy

• Osteoporosis

• Traumatic brain injury

• Heart disease /Heart attack

The concept of the endocannabinoid system was outlined a mere 14 years ago, and looks how far we have come!

Today “phytocannabinoid therapeutics” is the newest, fastest growing field in medical research.

As this medical cannabis evidence-based tsunami approaches, its main therapeutic action appears to restoring homeostasis to multiple body systems.

The action by which phytocannabinoids heal is by reestablishing the proper immune set points within CB 1/2 receptors in both brain and body.

Research supports medical cannabis as important a medical discovery as insulin or penicillin were in their day.

Perhaps the root of many human illnesses is an anandamide deficiency, which, when corrected and rebalanced by THC intake, produces homeostasis.

Whatever anandamide does in the body, phytocannabinoids mimic. My prediction is that phytocannabinoids will ultimately be found to be an vital to human health.

Phytocannabinoids mimic the same actions of Anandamide in the brain and body, which maintain homeostasis, maintaining wellness and disease prevention!    

Graphic: TRENDS In Pharmacological Sciences

Pharmacological actions of non-psychotropic cannabinoids (with the indication of the proposed mechanisms of action). Abbreviations: D 9 -THC, D 9 -tetrahydrocannabinol; D 8 -THC, D 8 -tetrahydrocannabinol; CBN, cannabinol; CBD, cannabidiol; D 9 -THCV, D 9 -tetrahydrocannabivarin; CBC, cannabichromene; CBG, cannabigerol; D 9 -THCA, D 9 -tetrahydrocannabinolic acid; CBDA, cannabidiolic acid; TRPV1, transient receptor potential vanilloid type 1; PPARg, peroxisome proliferator-activated receptor g; ROS, reactive oxygen species; 5-HT1A, 5-hydroxytryptamine receptor subtype 1A; FAAH, fatty acid amide hydrolase. (+), direct or indirect activation; “, increase; #, decrease.

​

It’s All About THC

THC is unique, in that it is only found in one plant on earth.

Photo: Rhinoseeds

Power Flower strain

​ The female cannabis plant is a THC-resin factory. THC, which makes up the plant’s resin, has the important job of collecting pollen from the male plant for fertilization. No THC-laced resin, no seed production.  Additionally, this resin tastes very bad to herbivores, which leave it alone, and it also offers superior UV protection to the plant at high altitudes.

A cannabis sativa flower coated with trichomes, which contain more THC than any other part of the plant

The cannabis plant has only two functions: to make THC and seeds.

THC is the most abundant “phytocannabinoid” within the cannabis plant.

All other THC-like substances in the plant are THC intermediate metabolites being assembled by the plant on their way to becoming THC.

Once the plant is cut down and dies, the THC degrades into cannabindiol.  Cannabinol (CBN) is the primary product of THC degradation, and there is usually little of it in a fresh plant. CBN content increases as THC degrades in storage, and with exposure to light and air, and it is only mildly psychoactive.

Why would just this one plant, and the phytocannabinoids it produces control not one, but two dedicated molecular receptors for phytocannabinoids, with more predicted to still be discovered?

Did evolution intend for them to be naturally consumed for proper body function? As any other plant-derived antioxidant?

How THC talks to the brain and immune system

Graphic: How Stuff Works

​All healing, cancer fighting and aging in your body is controlled by the immune system.

Phytocannabinoids appear to control the activity level of the immune system up or down, so that it doesn’t attack its host or respond too weakly to cellular dysfunction. Whenever you hear the term “anti-inflammatory activity,” think “cannabis immune system control.”

CB1 cannabigenic receptors are the majority of receptor type in the synaptic clef. THC-activated CB1 brain receptors directly link up and control the microglial cells in the brain; the microglia is the specialized white blood cells that make up the brain’s dedicated immune system.

Cannabidiol is degraded THC. It activates CB2 receptors mostly in the body. In both cases, THC controls both immune systems (brain and body), in one form or another. It seems that CB1 brain receptors link up to CB2 body receptors, which in turn control many autoimmune diseases.

The word used to describe this cannabis brain/body link up is Psychoneuroimmunology.

Mind = neurotransmitter = immune system communication system, or in this case “Cannabingenic Psychoneuroimmunology” — THC-induced immune system healing .

Cannabis consciousness repairs your immune system: never underestimate the power of a bong hit!

#1:   “The Endocannabinoid System and Cancer: Therapeutic Implication” 

The British Journal of Pharmacology, 2011 

Photo: WhyProhibition.ca

​Findings: Delta 9 THC as a treatment for breast, prostate, brain and bone cancer

“This review updates the relationship between the endocannabinoid system and anti-tumor actions (inhibition of cell proliferation and migration, induction of apoptosis, reduction of tumor growth) of the cannabinoids in different types of cancer.”

“The therapeutic potential of cannabinoids for cancer, as identified in clinical trials, is also discussed. Identification of safe and effective treatments to manage and improve cancer therapy is critical to improve quality of life and reduce unnecessary suffering in cancer patients.”

“In this regard, cannabis-like, compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients. Further basic research on anti-cancer properties of cannabinoids as well as clinical trials of cannabinoid therapeutic efficacy in breast, prostate and bone cancer is therefore warranted.”

“The available literature suggests that the endocannabinoid system may be targeted to suppress the evolution and progression of breast, prostate and bone cancer as well as the accompanying pain syndromes. Although this review focuses on these three types of cancer, activation of the endocannabinoid signaling system produces anti-cancer effects in other types of cancer including skin, brain gliomas and lung.”

“Interestingly, cannabis trials in population based studies failed to show any evidence for increased risk of respiratory symptoms/chronic obstructive pulmonary disease or lung cancer (Tashkin, 2005) associated with smoking cannabis.”

“Moreover, synthetic cannabinoids (Delta 9 THC) and the endocannabinoid system play a role in inhibiting cancer cell proliferation and angiogenesis, reducing tumor growth and metastases and inducing apoptosis ( self destruction for cancer cells) in all three types of cancers reviewed here.

“These observations raise the possibility that a dysregulation of the endocannabinoid system may promote cancer, by fostering physiological conditions that allow cancer cells to proliferate, migrate and grow.”

IMPORTANT: This is a very intriguing observation. What is being implied here is that some people may be suffering from an anandamide deficiency! Just as a diabetic is insulin deficiencient and must supplement their body with insulin, in this case THC is the vital medicine needed to replace low levels of anandamide.

These observations also raise the exciting possibility that enhancing cannabinoid tone (code for THC locking into the CB1 receptor) through cannabinoid based pharmacotherapies may attenuate these harmful processes to produce anti-cancer effects in humans.

Bottom line:  Smoking marijuana prevents cancer body-wide.

#2:  “Update on the Endocannabinoid System as an Anticancer Target” 

Expert Opinion on Therapeutic Targets, March 2011

Graphic: Americans for Safe Access

​Findings: antitumor effects, cancer prevention

“Recent studies have shown that the endocannabinoid system (ECS) could offer an attractive antitumor target. Numerous findings suggest the involvement of this system (constituted mainly by cannabinoid receptors, endogenous compounds and the enzymes for their synthesis and degradation) in cancer cell growth in vitro and in vivo.”

“This review covers literature from the past decade which highlights the potential of targeting the ECS for cancer treatment. In particular, the levels of endocannabinoids and the expression of their receptors in several types of cancer are discussed, along with the signaling pathways involved in the endocannabinoid antitumor effects.”

“Furthermore, targeting the ECS with agents that activate cannabinoid receptors (This means THC) or inhibitors of endogenous degrading systems such as fatty acid amide hydrolase inhibitors may have relevant therapeutic impact on tumor growth. Additional studies into the downstream consequences of endocannabinoid treatment are required and may illuminate other potential therapeutic targets.”

#3:  “Cannabinoids and the gut: new developments and emerging concepts”

Pharmacology & Therapeutics, April, 2010

Photo: Top News

​Findings: THC and inflammatory bowel disease, irritable bowel syndrome (IBS), colitis, colon cancer, vomiting/chemotherapy

“Disorders of the gastrointestinal (GI) tract have been treated with herbal and plant-based remedies for centuries. Prominent amongst these therapeutics are preparations derived from the marijuana plant Cannabis.  Cannabis has been used to treat a variety of GI conditions that range from enteric infections and inflammatory conditions, including inflammatory bowel disease (IBD) to disorders of motility, emesis and abdominal pain.”

“Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric infections and inflammatory conditions to disorders of motility, emesis and abdominal pain.”

“The mechanistic basis of these treatments emerged after the discovery of Delta(9)-tetrahydrocannabinol as the major constituent of Cannabis. Further progress was made when the receptors for Delta(9)-tetrahydrocannabinol were identified as part of an endocannabinoid system, that consists of specific cannabinoid receptors.”

Sites of action of cannabinoids in the enteric nervous system. CB2 receptors indicated with the marijuana leaf.

​  “Anatomical, physiological and pharmacological studies have shown that the endocannabinoid system is widely distributed throughout the gut, with regional variation and organ-specific actions.” (CB2 receptors are embedded within the lining of the intestines in large numbers.)

“They are involved in the regulation of food intake, nausea and emesis, gastric secretion and gastro protection, GI motility, ion transport, visceral sensation, intestinal inflammation and cell proliferation in the gut.”

“As we have shown, the endocannabinoid system is widely distributed throughout the gut, with regional variation and specific regional or organ-specific actions.”

“CB2 receptors are involved in the regulation of food intake, nausea and emesis, gastric secretion and gastro protection, GI motility, ion transport, visceral sensation, intestinal inflammation and cell proliferation (cancer)”

How THC/cannabidiol activates the CB1/2 receptors to shut down colon cancer by signaling cancer cells to self-destruct

​ “Preclinical models have shown that modifying the endocannabinoid system can have beneficial effects…. Pharmacological agents that act on these targets have been shown in preclinical models to have therapeutic potential.” [THC is the Pharmacological agent mentioned.]

Colorectal Cancer Prevention Model

Cannabiols via CB1 and possibly CB2 receptor activation, have been shown to exert apoptotic actions in several colorectal cancer cell lines.

See the illustration at left for how THC/cannabidiol activates the CB1/2 receptors to shut down colon cancer by signaling cancer cells to self-destruct.

#4:   “Gut feelings about the endocannabinoid system”

Journal of Gastrointestinal Motility, May 2011

Graphic: CMR Journal

Schematic illustration of the functional roles of the endocannabinoid system (ECS) in the gastrointestinal tract. The ECS regulates four major functional elements in the gut: motility, secretion, inflammation, and sensation in health and disease. Major components of the ECS that have been defined in each of these functional roles are shown: CB1 and CB2 receptors, anandamide (AEA), fatty acid amide hydrolase (FAAH), and the endocannabinoid membrane transporter (EMT). For motility, the CB2 receptors only appear to be active under pathophysiological conditions and are shown italicized.

​ Findings: Stemming from the centuries-old and well known effects of Cannabis on intestinal motility and secretion, research on the role of the endocannabinoid system in gut function and dysfunction has received ever increasing attention since the discovery of the cannabinoid receptors and their endogenous ligands, the endocannabinoids.

In this article, some of the most recent developments in this field are discussed, with particular emphasis on new data, most of which are published in Neurogastroenterology & Motility, on the potential tonic endocannabinoid control of intestinal motility, the function of cannabinoid type-1 (CB1) receptors in gastric function, visceral pain, inflammation and sepsis, the emerging role of cannabinoid type-2 (CB2) receptors in the gut, and the pharmacology of endocannabinoid-related molecules and plant cannabinoids not necessarily acting via cannabinoid CB1 and CB2 receptors.

These novel data highlight the multi-faceted aspects of endocannabinoid function in the GI tract, support the feasibility of the future therapeutic exploitation of this signaling system for the treatment of GI disorders, and leave space for some intriguing new hypotheses on the role of endocannabinoids in the gut.

#5: “Cannabinoids and the skeleton: from marijuana to reversal of bone loss”

Annuals of Medicine, 2009

Graphic: Medicinal Cannabis

​Findings: CB2 receptors maintain bone remodeling balance, thus protecting the skeleton against age-related bone loss.

The active component of marijuana, Delta(9)-tetrahydrocannabinol, activates the CB1 and CB2 cannabinoid receptors, thus mimicking the action of endogenous cannabinoids.

CB1 is predominantly neuronal and mediates the cannabinoid psychotropic effects. CB2 is predominantly expressed in peripheral tissues, mainly in pathological conditions. So far the main endocannabinoids, anandamide and 2-arachidonoylglycerol, have been found in bone at ‘brain’ levels.

The CB1 receptor is present mainly in skeletal sympathetic nerve terminals, thus regulating the adrenergic tonic restrain of bone formation. CB2 is expressed in osteoblasts and osteoclasts, stimulates bone formation, and inhibits bone resorption.

Because low bone mass is the only spontaneous phenotype so far reported in CB2 mutant mice, it appears that the main physiologic involvement of CB2 is associated with maintaining bone remodeling at balance, thus protecting the skeleton against age-related bone loss.

Indeed, in humans, polymorphisms in CNR2, the gene encoding CB2, are strongly associated with postmenopausal osteoporosis. Preclinical studies have shown that a synthetic CB2-specific agonist rescues ovariectomy-induced bone loss.

Taken together, the reports on cannabinoid receptors in mice and humans pave the way for the development of 1) diagnostic measures to identify osteoporosis-susceptible polymorphisms in CNR2, and 2) cannabinoid drugs to combat osteoporosis.

#6:  “Endocannabinoids and traumatic brain injury“

Graphic: Fit Body Bootcamp

​​Findings: Traumatic brain injury (TBI) represents the leading cause of death in young individuals.

FINDING:  THC activation of the CB1 receptor is the same as the action of anaidemide on CB1 This article discusses how anandamide increases in the brain after injury, so THC may have the potential to become a front line emergency medicine in the future.

“There is a large body of evidence showing that eCB are markedly increased in response to pathogenic traumatic head injury events.”

“This fact, as well as numerous studies on experimental models of brain toxicity, neuroinflammation and trauma supports the notion that the eCB are part of the brain’s compensatory or repair mechanisms.”

These are mediated via CB receptors signalling pathways that are linked to neuronal survival and repair. The levels of 2-AG, the most highly abundant eCB, are significantly elevated after TBI and when administered to TBI mice, 2-AG decreases brain edema, inflammation and infarct volume and improves clinical recovery.( So would THC.)

This review is focused on the role the eCB system plays as a self-neuroprotective mechanism and its potential as a basis for the development of novel therapeutic modality for the treatment of CNS pathologies with special emphasis on TBI.

Bottom line:  For proof see U.S government 2003 patent

#7:  “Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion”

British Journal of Pharmacology, Aug. 2011 

Graphic: Cannabis N.I.

Not only is CBD cardioprotective — it is also an anti-epileptic, sedative, anxiolytic, antipsychotic, antioxidant, neuroprotectant, anti-inflammatory, anti-diabetic, anti-emetic, and anti-tumorant.

​ Findings:  Cannabidiol (CBD) is a phytocannabinoid, with anti-apoptotic, (the process of programmed cell death) anti-inflammatory and antioxidant effects and has recently been shown to exert a tissue sparing effect during chronic myocardial ischaemia and reperfusion (I/R).

However, it is not known whether CBD is cardioprotective in the acute phase of I/R injury and the present studies tested this hypothesis.

EXPERIMENTAL APPROACH: Male Sprague-Dawley rats received either vehicle or CBD (10 or 50 microg kg(-1) i.v.) 10 min before 30 min coronary artery occlusion or CBD (50 microg kg(-1) i.v.) 10 min before reperfusion (2 h). The appearance of ventricular arrhythmias during the ischaemic and immediate post-reperfusion periods were recorded and the hearts excised for infarct size determination and assessment of mast cell degranulation. Arterial blood was withdrawn at the end of the reperfusion period to assess platelet aggregation in response to collagen.

KEY RESULTS: “CBD reduced both the total number of ischaemia-induced arrhythmias and infarct size when administered prior to ischaemia, an effect that was dose-dependent. Infarct size was also reduced when CBD was given prior to reperfusion. CBD (50 microg kg(-1) i.v.) given prior to ischaemia, but not at reperfusion, attenuated collagen-induced platelet aggregation compared with control, but had no effect on ischaemia-induced mast cell degranulation.”

CONCLUSIONS AND IMPLICATIONS: “This study demonstrates that CBD is cardioprotective in the acute phase of I/R by both reducing ventricular arrhythmias and attenuating infarct size. The anti-arrhythmic effect, but not the tissue sparing effect, may be mediated through an inhibitory effect on platelet activation.”

Remember to exercise your ganja rights! Every day is a Ganja day!

Photo: Ron Marczyk

Mr. Worth Repeating: former NYPD cop, former high school health teacher, the unstoppable Ron Marczyk, R.N., Toke of the Town columnist

In response to this growing population and the need for education about alternative medical solutions, the Apothecary Senior Citizens Project was started.

The purpose of the project was to educate seniors, their caregivers and loved ones about the science behind cannabis, its use with different aliments and application methods. The Apothecary Senior Citizens Project brings seminars and education to conveient locations for seniors and incorporates people of their own age group in the learning process.

Many times a Senior citizen would rather listen to the advice of someone their own age dealing with similar health concerns or from respected medical professionals. There have been several events held since the inception.

The first event held was The Medical Cannabis Conference sponsored by Apothecary Genetics, GGECO University, and Orange County NORML, a chapter of the National Organization for the Reform of Marijuana Laws.

The Conference was held in the gated senior community of Laguna Woods, at the city auditorium in Orange County on Saturday, January 22, 2011. Several hundred people attended the Conference, which featured spectacular panels and speakers from prestigious hospitals and research groups from around the country.

The two featured speakers at the conference were Dr. Donald Abrams from University of California San Francisco Medical School and San Francisco General Hospital Oncology Director, and Dr. William Courtney from Mendocino, CA. Seniors learned about the background of Medicinal Cannabis, current research, and alternative methods of delivery that may be beneficial to their quality of health.

Following the Medical Cannabis Conference, several small retirement and religious senior groups have inquired about follow up seminars.

One seminar was recently held at the Jewish Temple Beth Ezmet in Anaheim. The seniors seemed very interested in the new knowledge they acquired and had many good follow up questions to ask.

The Apothecary Senior Citizens Project has been invited to present another conference in June to provide more education and help seniors to make informed health decisions about their own body.

Additional seminars at other retirement communities are planned.

The Medical Cannabis Conference video with presentations of all speakers and panels will be available soon at http://www.ApothecaryGenetics.com for $10.

For more information about senior seminars please contact Kandice Hawes at Apothecary Public Relations Kandice@ApothecaryGenetics.com or call 714-928-9129.

Bogue loves to teach marijuana cultivation techniques such as “super-cropping,” and he revels in developing or improving strains such as Grape Ape, Tangerine Kush, ChemDawg, Kaia Kush, Sour Grapes, Goo, Levity, and Very Berry Haze.

It’s no surprise they call Bret the “King of Kush.” Big Buds caught up with Bret Bogue as he multi-tasked his way through another OG Kush day in California…

Big Buds: Bret, when I heard them call you the King of Kush, I knew I had to start by asking you about the origins of Kush.
Bret Bogue: OG Kush is originally from Pakistan and Afghanistan. Seeds were gathered in that region and brought to Florida in the early 1970’s and was grown there in the Latin American community until the late 1980’s. By 1992, it had been brought to California. A young breeder named Josh started making a buzz with OG Kush in the Hollywood/LA scene. By 1995, Josh had given it to TH Seeds in Amsterdam, which is run by Adam Dunn. He also gave it to B-Real from Cypress Hill. Thanks in part to these three people, OG Kush became a hugely sought-after strain, with a top value of $7500 per pound. Nowadays, there are many different variations of OG Kush, such as Larry OG, Snoop OG, Valley OG, Tahoe OG, and on and on. Many seed companies claim to have seeds of OG Kush, but there are so many variations, it’s difficult to know if you have the actual, original OG Kush. The original is an Indica-based strain but over the years OG Kush has been crossbred into many different hybrids.

Big Buds: I heard that OG Kush is somehow related to Chemdawg.
Bret: Chemdawg originated on the East coast of USA. There were 5 friends who created Chemdawg, Chemdawg 91, and Chem D. These strains can only be found in cutting form. There are certain companies who claim to have original seeds, but at this point, there’s no proof to back that up. The crew continues to work on the east coast. Chemdawg is a hybrid Indica/Sativa mix.

See the full article here: http://bigbudsmag.com/grow/article/king-kush-marijuana-july-2011

GGECO Basic Course:
• 101 – Understanding the Law
• 101 – Medical Cannabis
• 101 – Cooking – Cannabis in the Kitchen
• 101 – Horticulture
• 101 – Budtending

GGECO Advanced Course
• 201 – Medical Cannabis with Dr. Courtney
• 201 – Horticulture with Bret Bogue
• 201 – Law – Dispensary
• 202 – Law – Non-Profit

Test exams are available for Horticulture 101 and 201, Cooking 101, & Budtending. Passing the entire Basic and/or Advanced Course awards a GGECO University Medical Cannabis Diploma!

As seen in the explosive movie by Kevin Booth, “How Weed Won The West,” GGECO University is headed by HIGH TIMES Cannabis Cup Champion Bret Bogue!

Classes now also available in Spanish! Disponible en español.

For more information, visit GGECOUniversity.com!

‎

Buddha Fest

"The Whole World is Watching"

CANNABIS Awareness Event

November 2nd 2010
California will have a chance to vote on Prop 19 which will determine the
legality of Cannabis in the state of California.

"UNDER A BEAUTIFUL FULL MOON NIGHT"

Buddha Fest is neither for nor against Prop 19 and
is defined in our eyes as a neutral place of awareness that believes all adults
21 years of age should be free to choose what they like and dislike. Buddha
Fest is open to both sides of the argument to voice their humble opinion on Prop
19.

Saturday Oct. 23rd, 2010

12 PM Noon – 2:00 AM

All Music Genres Unite
Bringing Awareness 

for the Historic
Vote for Cannabis Nov. 2nd…

Special Honored Guests:

7th ANNUAL 

2010 JACK HERER
AWARDS

Most Distinguished Name in Hemp

Hosted by MedMike   (Founder
& Executive Producer)

HIGH TIMES MAGAZINE

20 years
of Cannabis Photography 

by DAN SKY   (Senior
Editor of  HIGH TIMES)

Musical Performances by:

FAITH EVANS   Hip-Hop
and R&B Royality Legend

"Multi Platinum Selling & Grammy Award Winning
Artist"

DOC MARTIN  (www.sublevelcalifornia.com)

"Old School DJ Icon"

SHINEHEAD (www.myspace.com/originalshinehead)

"Legendary Jamaican Reggae
Singer/Toaster/Rapper"

GOLDEN BUDDHA (GoldenBuddhaMusic.com)

"Psychedelic Legends"

FREEDOM (Freedom
Recordz)

ELECTRIC SKYCHURCH (skychurch.com)

"Original Electronica Superstars"

DANIEL MOONTRIBE (automat
records) with MC CONTRABAN

"THE ORIGINAL MOONTRIBE Desert DJ"

MARK TRANCE LIVE (marktrance.com)

"LA's 1st & Original Live Electronica Wizard"

HEAR KITTY KITTY (EFM/Universal)

STREET DRUM CORP

CHRIS ROB

LOS MARIJUANOS (sunset
records)

JUN (Umojo
HI-FI)

"OG Science and Bossa Nova" 

STATIC PULSE

GRANDDADDY PURP

MICHAEL JOST

TAMMER

DJ 80.BUG  (80bug.com)
 "Super
Desert Shiva Djiva"

DEVINE CRIME

Human Revolution

& more Top Named Bands and
DJ's to be Announced!

Special Guests:

GARY JOHNSON (REP.) FORMER GOV. NEW MEXICO

"Hopeful Republican 2012 Presidential
Nominee"  

JUDY MENDOZA (MSquared)
Mama 2 Mama Group

"Recently seen on ABC 20/20"

RICHARD DAVIS (LOS
ANGELES.) HEMP MUSEUM  

"Hemp Icon Curator & Activist for 25 Years"

JORGE CERVANTES (LEGENDARY
CANNABIS GROWER) 

"Rated one of the World's Top Green Thumb for Marijuana"

MELISSA BALIN (Film
Maker)

ADAMACADOCIOUS

MANNY BLUNTS

ROB VAN DAM

& more
Top Named Speakers to be Announced!

Comedians:

ERIC SCHWARTZ  A.K.A.   SMOOTH-E
 (www.smoothE.tv) 

"#1 Myspace Comedian"

TOBE HIXX

"Comedy Central, HBO"

G REILLY

JEFFREY PETERSON     (420
Comic Show) 

"Show Dopest
Show on Earth"

COREY CRAIG

TERE JOYCE

& more Top Named Comedian's
to be Announced!

Performances by:

HOOPMON

20 Local Food Trucks and a FULL BAR

Buddha Fest
will have 10 staging areas:

SOUR DIESEL STAGE, CLUB BUBBLEGUM, KING
KUSH LOUNGE

INDICA
THEATRE, MUNCHIE LAND LOUNGE VIP

CLUB
TRAIN WRECK VIP ,TRICHROME
DOME VIP (A-List) , 

WHITE WIDOW ROOFTOP VIP (A-List), STONERLAND
ART PARK, 

EXPOSE
VENDOR VILLAGE  with Live Music, DJ’s, Art, Vendors and more.

There is an several acres of space to walk around in a daze, listen to music and

look at the Art Park and view all the
Vendors selling their products.

60 hand selected vendors will be there to promote and sell some of there
products.

"LIVE STREAMING" via the Web

100 Performers

Top Political Speakers Pro and Con

Indie and Documentary Films

Cannabis Industry Lifetime Achievement Awards

VENDOR INFO: 213.493.4093  DIRECT: 213.926.5545

Tickets Presale: $30

Day of Event: $40 (1st
Tier)

VIP $300 (Includes
free Medical Marijuana Evaluation provided by CALMED420)

Tickets available: Groovetickets

http://www.groovetickets.com

Tickets By Phone 1-877-71-GROOV (47668)

EVENT INFORMATION:
www.BuddhaFest.com

Los Angeles Center Studios

GATE ENTRANCE:

1037
W. 6th St.

Los
Angeles CA 90017

Sponsored by:

THC EXPOSE,
STONER GENERATION, VAPOR BROTHERS, JACK HERER AWARDS, DNA, SHELDON BLACK